SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DebtBomb who wrote (82716)6/21/2002 8:16:48 AM
From: shoreco  Read Replies (1) of 99280
 
Dale, It's stuff like this that will keep Mom and Pop out...

** Merck Sinks in Premarket Trading on Report **

7:06AM Merck books co-payments to pharmacies as revenue (MRK) 52.20: The Wall Street Journal reports that MRK and its Medco pharmacy-benefits unit have boosted their reported rev by billions of dollars in 2001 alone by booking co-payments, an accounting practice not used by competitors ADVP and ESRX, which use a more conservative accounting method; the accounting treatment was disclosed to investors for the first time in an SEC filing in April in preparation for an initial public offering of stock in Medco. The article notes that CMX also includes co-payments when calculating rev.

Full story link...
biz.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext